OPKO Health Inc
XMUN:XCY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
OPKO Health Inc
XMUN:XCY
|
US |
|
E
|
Empresas Copec SA
SGO:COPEC
|
CL |
|
L
|
Lixil Corp
F:TJS
|
JP |
|
AVITA Medical Inc
NASDAQ:RCEL
|
US |
|
N
|
Nishat Power Ltd
KAR:NPL
|
PK |
|
Y
|
Yonghe Medical Group Co Ltd
F:L97
|
CN |
|
G
|
Graphisoft Park SE Ingatlanfejleszto Europai Rt
F:GUV
|
HU |
|
KYB Corp
F:60V
|
JP |
|
I
|
Invesco Mortgage Capital Inc
F:7M2
|
US |
|
E
|
Empire State Realty Trust Inc
F:ES9
|
US |
|
M
|
Matson Inc
F:68M
|
US |
|
S
|
Surteco Group SE
XMUN:SUR
|
DE |
|
Betterware de Mexico SAPI de CV
F:BM0
|
MX |
Wall St Price Targets
XCY Price Targets Summary
OPKO Health Inc
According to Wall Street analysts, the average 1-year price target for XCY is 4 EUR with a low forecast of 2.72 EUR and a high forecast of 8.01 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is XCY's stock price target?
Price Target
4
EUR
According to Wall Street analysts, the average 1-year price target for XCY is 4 EUR with a low forecast of 2.72 EUR and a high forecast of 8.01 EUR.
What is the Revenue forecast for OPKO Health Inc?
Projected CAGR
3%
Over the last 1 year, the compound annual growth rate for Revenue has been -15%. The projected CAGR for the next 8 years is 3%.
What is the Gross Profit forecast for OPKO Health Inc?
Projected CAGR
6%
Over the last 1 year, the compound annual growth rate for Gross Profit has been -6%. The projected CAGR for the next 5 years is 6%.
